1. Home
  2. NEWP vs CATX Comparison

NEWP vs CATX Comparison

Compare NEWP & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEWP
  • CATX
  • Stock Information
  • Founded
  • NEWP 1972
  • CATX 1983
  • Country
  • NEWP Canada
  • CATX United States
  • Employees
  • NEWP N/A
  • CATX N/A
  • Industry
  • NEWP
  • CATX Medical/Dental Instruments
  • Sector
  • NEWP
  • CATX Health Care
  • Exchange
  • NEWP Nasdaq
  • CATX Nasdaq
  • Market Cap
  • NEWP 259.4M
  • CATX 239.0M
  • IPO Year
  • NEWP N/A
  • CATX N/A
  • Fundamental
  • Price
  • NEWP $1.45
  • CATX $3.67
  • Analyst Decision
  • NEWP
  • CATX Strong Buy
  • Analyst Count
  • NEWP 0
  • CATX 11
  • Target Price
  • NEWP N/A
  • CATX $12.90
  • AVG Volume (30 Days)
  • NEWP 287.8K
  • CATX 954.5K
  • Earning Date
  • NEWP 09-23-2025
  • CATX 08-13-2025
  • Dividend Yield
  • NEWP N/A
  • CATX N/A
  • EPS Growth
  • NEWP N/A
  • CATX N/A
  • EPS
  • NEWP N/A
  • CATX N/A
  • Revenue
  • NEWP N/A
  • CATX $1,471,000.00
  • Revenue This Year
  • NEWP N/A
  • CATX N/A
  • Revenue Next Year
  • NEWP N/A
  • CATX $11.99
  • P/E Ratio
  • NEWP N/A
  • CATX N/A
  • Revenue Growth
  • NEWP N/A
  • CATX N/A
  • 52 Week Low
  • NEWP $0.93
  • CATX $1.60
  • 52 Week High
  • NEWP $2.05
  • CATX $16.55
  • Technical
  • Relative Strength Index (RSI)
  • NEWP 39.89
  • CATX 44.88
  • Support Level
  • NEWP $1.61
  • CATX $3.88
  • Resistance Level
  • NEWP $1.71
  • CATX $4.28
  • Average True Range (ATR)
  • NEWP 0.10
  • CATX 0.27
  • MACD
  • NEWP -0.04
  • CATX -0.08
  • Stochastic Oscillator
  • NEWP 13.18
  • CATX 2.32

About NEWP New Pacific Metals Corp.

New Pacific Metals Corp is a Canadian Mining Issuer, in the business of exploring and developing precious metal properties in Bolivia. The company's projects which are also its reportable segments include Silver Sand; Carangas and Silverstrike.

About CATX Perspective Therapeutics Inc.

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Share on Social Networks: